pipevef.blogg.se

1. #QIAGEN CLC GENOMICS WORKBENCH FULL#
2. #QIAGEN CLC GENOMICS WORKBENCH SOFTWARE#
3. #QIAGEN CLC GENOMICS WORKBENCH SERIES#

Researchers actively involved in SARS-CoV-2 genomics and bioinformatics in government or academic laboratories are entitled to a ‘temporary 14-day license’ for QIAGEN CLC Genomics Workbench Premium which allows them a license to use the software at no cost. QIAGEN Digital Insights may extend these licenses should the need arise. Subject to your consent given above, by clicking on "submit," QIAGEN may use your personal information to communicate with you regarding this topic. QIAGEN may also use your personal information for internal business and marketing purposes that may include regular promotional offers, news, invitations via email or telephone.The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by, Inc. and Oracle Corp.) solely for the purposes of data hosting, phone calls and QIAGEN email distribution. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation.

#QIAGEN CLC GENOMICS WORKBENCH FULL#

Key elements include developing and commercializing an innovative sample-to-insight workflow incorporating the GeneReader™ benchtop NGS sequencer with the QIAcube and QIAcube NGS instruments for full automation of pre-analytical steps, and also integrating the market-leading biological data analysis, interpretation and reporting capabilities provided by CLC bio and Ingenuity.All information you provide in this site will be governed by our Privacy Policy. QIAGEN is delivering on a strategic initiative to create an industry-leading portfolio of products and services to drive the adoption of next-generation sequencing (NGS) in clinical research and diagnostics. NGS initiative from biological sample to valuable molecular insights The “cross-platform” systems offered by CLC bio support all major NGS platforms. CLC bio’s leading products are CLC Genomics Workbench, a comprehensive and user-friendly analysis package for analyzing, comparing and visualizing NGS data and CLC Genomics Server, a flexible enterprise-level infrastructure and analysis backbone for NGS data analysis. The addition of this portfolio follows QIAGEN’s recent acquisition of Ingenuity Systems, Inc., the market leader in solutions for handling biological data through the interpretation and reporting stages.

#QIAGEN CLC GENOMICS WORKBENCH SERIES#

CLC bio’s products are used as an integrating workbench to handle biological data generated by a sequencer through a series of analysis stages. It serves leading research institutions and top pharmaceutical companies worldwide. It strengthens QIAGEN’s rapidly emerging portfolio of “universal” products that can be used with any NGS sequencer as well as providing a key element to the portfolio of automated solutions for the GeneReader™ benchtop NGS sequencer workflow, which is currently in late-stage development.ĬLC bio, a privately-held company based in Aarhus, Denmark, was founded in 2005 and has created the leading commercial data analysis solutions and workbenches for NGS.